FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40276711000001105: Xofluza 40mg tablets (Roche Products Ltd) 2 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Dec 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2106421000001111 Xofluza 40mg tablets (Roche Products Ltd) 2 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2106441000001118 Xofluza 40mg tablets (Roche Products Ltd) 2 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Is a Baloxavir marboxil 40mg tablets 2 tablet true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has AMP Xofluza 40mg tablets (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has specific active ingredient Baloxavir marboxil true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xofluza 40mg tablets (Roche Products Ltd) 2 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start